PNC Financial Services reduced its holdings in Regeneron Pharmaceuticals by 8.8% in the fourth quarter, selling 1,608 shares. Other institutional investors have also adjusted their positions, with ...

Lifeworks Advisors LLC increased its stake in Regeneron Pharmaceuticals by 31.5%, now holding 6,743 shares worth $4.8 million ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The fund outperformed its benchmark and peers for the final quarter and full year 2024, driven by positive stock selection.

Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $134,486.89 today based ...

Leerink Partners 2025 Global Healthcare Conference Call March 11, 2025 8:00 AM ET. Company Participants. Ryan Crowe - SVP, IR & Strat ...

Real-time index price for KBW Finsec Dividend Yield Index (KDX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Key Takeaways The S&P 500 dropped 2.7% on Monday, March 10, as U.S. tariffs and government job cuts heightened economic ...

+ Company announcements and prices are delayed by least 20 minutes. Prices are indicative only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $745.98, up $38.47 or 5.44% --Would be highest close since Dec. 11, 2024, when it closed at $773.00 --On pace for largest percent increase since ...